Tim Anderson

Mr. Anderson is a Partner, Head of Research and a co-founding member of Cowen Healthcare Investments. Mr. Anderson focuses on investments in biotechnology, diagnostics and digital medicine companies that have the potential to meaningfully address serious medical conditions. He is currently a member of the Board of Directors of Tourmaline Bio, Lycia Therapeutics, F2G, Anaveon AG, Autobahn Therapeutics and Scipher. Mr. Anderson previously served as a Board Member or Board Observer of Vectiv Bio Holdings AG, Therachon Holdings AG, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology and Compass Therapeutics.  Prior to his role at Cowen Healthcare Investments, Mr. Anderson was a biotechnology investment banker at Cowen where he worked on a range of financings and mergers and acquisitions.

Mr. Anderson holds a BA in economics from Bowdoin College.